| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Laboratory of Experimental Immunology, Division of Basic Sciences, and
Intramural Research Support Program, Science Applications International Corporation-Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702;
University of Oklahoma, Health Sciences Center, Oklahoma City, OK 73104; and
§
Laboratory of Biological Chemistry, National Institute of Aging, National Institutes of Health, Baltimore, MD 21224.
Murine NK cells express Ly-49 family receptors capable of either
inhibiting or activating lytic function. The overlapping patterns of
expression of the various receptors have complicated their precise
biochemical characterization. Here we describe the use of the Jurkat T
cell line as the model for the study of Ly-49s. We demonstrate that
Ly-49D is capable of delivering activation signals to Jurkat T cells
even in the absence of the recently described Ly-49D-associated chain,
DAP-12. Ly-49D signaling in Jurkat leads to tyrosine phosphorylation of
TCR
and requires Syk/Zap70 family kinases and arginine 54 of Ly-49D,
suggesting that Ly-49D signals via association with TCR.
Coexpression studies in 293-T cells confirmed the ability of Ly-49D to
associate with TCR. In addition, we have used this model to study
the functional interactions between an inhibitory Ly-49 (Ly-49G2) and
an activating Ly-49 (Ly-49D). Ly-49G2 blocks activation mediated by
Ly-49D in an immunoreceptor tyrosine-based inhibitory motif
(ITIM)-dependent manner. In contrast, Ly-49G2 was incapable of
inhibiting activation by the TCR even though human killer cell
inhibitory receptor (KIR) (KIR3DL2(GL183)) effectively inhibits TCR.
Both the ability of Ly-49G2 to block Ly-49D activation and the failure
of Ly-49G2 to inhibit TCR signaling were confirmed in primary murine NK
cells and NK/T cells, respectively. These data demonstrate the dominant
effects of the inhibitory receptors over those that activate and
suggest an inability of the Ly-49 type II inhibitory receptors to
efficiently inhibit type I transmembrane receptor signaling in T cells
and NK cells.
This article has been cited by other articles:
|
|
 |
|
  A. Rouhi, C. B. Lai, T. P. Cheng, F. Takei, W. M. Yokoyama, and D. L. Mager Evidence for high bi-allelic expression of activating Ly49 receptors Nucleic Acids Res., September 1, 2009; 37(16): 5331 - 5342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Rodriguez-Galan, D. Reynolds, S. G. Correa, P. Iribarren, M. Watanabe, and H. A. Young Coexpression of IL-18 Strongly Attenuates IL-12-Induced Systemic Toxicity through a Rapid Induction of IL-10 without Affecting its Antitumor Capacity J. Immunol., July 1, 2009; 183(1): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Merck, R. B. Voyle, and H. R. MacDonald Ly49D Engagement on T Lymphocytes Induces TCR-Independent Activation and CD8 Effector Functions That Control Tumor Growth J. Immunol., January 1, 2009; 182(1): 183 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Winkler-Pickett, H. A. Young, J. M. Cherry, J. Diehl, J. Wine, T. Back, W. E. Bere, A. T. Mason, and J. R. Ortaldo In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses J. Immunol., April 1, 2008; 180(7): 4495 - 4506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Ortaldo, R. Winkler-Pickett, J. Wigginton, M. Horner, E. W. Bere, A. T. Mason, N. Bhat, J. Cherry, M. Sanford, D. L. Hodge, et al. Regulation of ITAM-positive receptors: role of IL-12 and IL-18 Blood, February 15, 2006; 107(4): 1468 - 1475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Kirwan and D. N. Burshtyn Killer Cell Ig-Like Receptor-Dependent Signaling by Ig-Like Transcript 2 (ILT2/CD85j/LILRB1/LIR-1) J. Immunol., October 15, 2005; 175(8): 5006 - 5015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hart, L. Flaishon, S. Becker-Herman, and I. Shachar Tight Regulation of IFN-{gamma} Transcription and Secretion in Immature and Mature B cells by the Inhibitory MHC Class I Receptor, Ly49G2 J. Immunol., October 15, 2005; 175(8): 5034 - 5042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xie, H. He, M. Colonna, T. Seya, T. Takai, and B. A. Croy Pathways Participating in Activation of Mouse Uterine Natural Killer Cells During Pregnancy Biol Reprod, September 1, 2005; 73(3): 510 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Rodriguez-Galan, J. H. Bream, A. Farr, and H. A. Young Synergistic Effect of IL-2, IL-12, and IL-18 on Thymocyte Apoptosis and Th1/Th2 Cytokine Expression J. Immunol., March 1, 2005; 174(5): 2796 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. I. McFarland, S. A. Hansal, D. I. Morris, D. W. McVicar, P. E. Love, and A. S. Rosenberg Signaling through MHC in transgenic mice generates a population of memory phenotype cytolytic cells that lack TCR Blood, June 1, 2003; 101(11): 4520 - 4528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Voyle, F. Beermann, R. K. Lees, J. Schumann, J. Zimmer, W. Held, and H. R. MacDonald Ligand-dependent Inhibition of CD1d-restricted NKT Cell Development in Mice Transgenic for the Activating Receptor Ly49D J. Exp. Med., April 7, 2003; 197(7): 919 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Ortaldo and H. A. Young Expression of IFN-{gamma} Upon Triggering of Activating Ly49D NK Receptors In Vitro and In Vivo: Costimulation with IL-12 or IL-18 Overrides Inhibitory Receptors J. Immunol., February 15, 2003; 170(4): 1763 - 1769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hummel, D. Wilms, M. Vitacolonna, and M. Zoller Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host J. Leukoc. Biol., November 1, 2002; 72(5): 898 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Roger, A. Chalifour, S. Lemieux, and P. Duplay Cutting Edge: Ly49A Inhibits TCR/CD3-Induced Apoptosis and IL-2 Secretion J. Immunol., July 1, 2001; 167(1): 6 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Ortaldo, E. W. Bere, D. Hodge, and H. A. Young Activating Ly-49 NK Receptors: Central Role in Cytokine and Chemokine Production J. Immunol., April 15, 2001; 166(8): 4994 - 4999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Ortaldo, R. Winkler-Pickett, and G. Wiegand Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors J. Leukoc. Biol., November 1, 2000; 68(5): 748 - 756. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
